According to reports, at least 17,000 of the pills were labeled tramadol, and other tablets were labeled as lorazepam, zolpidem, diazepam, and alprazolam
This historical context is significant because it positions the industrys compounded GLP-1 expansion as a temporary opportunity that will diminish as branded supply stabilises
These medications include: Tirzepatide (Zepbound, Mounjaro) Semaglutide (Wegovy, Ozempic, Rybelsus) Liraglutide (Saxenda) Dulaglutide (Trulicity) These medications are part of Calibrates comprehensive Metabolic Reset, which combines GLP-1 treatment with lifestyle coaching, an evidence-based curriculum, and metabolic tracking for sustainable weight loss
doi:10.1038/nature22394 13
Obesity is the fastest-growing indication segment, driven by high-efficacy weight loss data, expanded regulatory approvals, and direct-to-consumer demand [1]